<\/p>\n\n\n\n
Molecular pathology of rare histologic variants and treatment-resistant lineages of prostate cancer<\/strong> Spatial gene expression profiling reveals the distinct microenvironment of tuberous sclerosis complex-associated angiomyolipoma<\/strong> Vesicles Secreted by Renal Cell Carcinoma Cells Cause Vascular Endothelial Cells to Express PSMA and Drive Tumor Progression<\/strong> CTHRC1 promotes bone metastasis in prostate cancer.<\/strong> Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer<\/strong> PSMA-positive membranes secreted from prostate cancer cells have potency to transform vascular endothelial cells into an angiogenic state<\/strong> SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex<\/strong> <\/p>\n\n\n\n Editorial Comment to \u201cPerioperative Systemic Treatment Patterns and Postoperative Mortality Among Patients With Muscle-Invasive Bladder Cancer Undergoing Radical Cystectomy in Japan: WAKKA-MIBC Study\u201d<\/strong> Clinical Outcomes of Single-Dose Flomoxef Prophylaxis for Transrectal Prostate Biopsy: A Single-Center Study of 834 Cases<\/strong> Validation of the NCCN Subclassification for Intermediate-Risk Prostate Cancer in a Japanese Radical Prostatectomy Cohort: Results From the MICAN Study<\/strong> Enzalutamide promotes an early plasticity-associated transcriptional state without terminal neuroendocrine differentiation in prostate cancer cells<\/strong> Dynamic Loss of Psoas Muscle Volume During Induction Chemotherapy Predicts Survival in Patients with Advanced Urothelial Carcinoma Receiving Avelumab Maintenance: A Multicenter Retrospective Study<\/strong> Single-Cell Analysis Reveals Pre-Existing Basal-Associated Epithelial States in Metastatic Hormone-Na\u00efve Prostate Cancer<\/strong> Cellular plasticity and tumor ecosystem dynamics in prostate cancer: insights from single-cell and spatial transcriptomics<\/strong> Paired-sample Analysis of ERG Expression and TMPRSS2-ERG Fusion in Treatment-induced Neuroendocrine Prostate Cancer<\/strong> Prostate\u2011specific membrane antigen: Molecular functions and emerging roles as a therapeutic target (Review)<\/strong> Molecular pathology of rare histologic variants and treatment-resistant lineages of prostate cancer<\/strong> Spatial transcriptomics of urothelial carcinoma with basal\/squamous differentiation identifies Galectin-7 as a specific marker of squamous lineage commitment<\/strong> Impact of the 2025 NCCN Definition Change for Very High-Risk Prostate Cancer on Surgical Outcomes After Robot-Assisted Radical Prostatectomy: A Retrospective Cohort<\/strong> A feasibility study of a novel irrigation technique for reducing intrapelvic pressure during ureterorenoscopy using conventional devices<\/strong> An inadequate number of first-line chemotherapy cycles provides poor survival outcomes in patients with metastatic urothelial carcinoma receiving avelumab maintenance: results from the chu-shikoku Japan urological consortium<\/strong> DNA Methylation Levels at the C3orf37 Loci Correlate With Prostate Cancer Grade<\/strong> Precision Medicine in Prostate Cancer with a Focus on Emerging Therapeutic Strategies<\/strong> Spatial gene expression profiling reveals the distinct microenvironment of tuberous sclerosis complex-associated angiomyolipoma<\/strong> CDH11 Contributes to Bladder Cancer Progression via Regulation of Mitochondrial Energy Metabolism<\/strong> Robot-Assisted Radical Prostatectomy for Locally Advanced Prostate Cancer: Oncological Potential and Limitations as the Primary Treatment<\/strong> Editorial Comment to \u201cVIRMA Accelerates the Tumorigenesis of Prostate Cancer via Regulating the m6A Modification of NSMCE2 to Eliminate the Generation of Reactive Oxygen Species\u201d<\/strong> Case Report: Chronic Prostatitis as an Extraintestinal Manifestation of Ulcerative Colitis<\/strong> Evaluation of the New Robotic Platform \u201cHINOTORI\u2122\u201d in Urologic Robot-Assisted Surgery: From a Comparison with da Vinci\u00ae Surgical System in Sacrocolpopexy<\/strong> Recent advances in basic research on prostate cancer: Where we are heading?<\/strong> Extended Lymph Node Dissection May Not Provide a Therapeutic Benefit in Patients with Intermediate-to High-Risk Prostate Cancer Treated with Robotic-Assisted Radical Prostatectomy<\/strong> Vesicles Secreted by Renal Cell Carcinoma Cells Cause Vascular Endothelial Cells to Express PSMA and Drive Tumor Progression<\/strong> Robot-Assisted Radical Nephroureterectomy in a Patient With Horseshoe Kidney: A Case Report<\/strong> CTHRC1 promotes bone metastasis in prostate cancer.<\/strong> Genetic Analysis of Intraductal Carcinoma of the Prostate Detected in High-Grade Prostatic Intraepithelial Neoplasia Cases<\/strong> A case of dedifferentiated liposarcoma discovered due to an intrascrotal calcified ossification<\/strong> Unveiling the Genomic Landscape of Intraductal Carcinoma of the Prostate Using Spatial Gene Expression Analysis<\/strong> Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer<\/strong> CD21(lo) B Cells Could Be a Potential Predictor of Immune-Related Adverse Events in Renal Cell Carcinoma<\/strong> Uhrf1 governs the proliferation and differentiation of muscle satellite cells.<\/strong> PSMA-positive membranes secreted from prostate cancer cells have potency to transform vascular endothelial cells into an angiogenic state<\/strong> Extended robot-assisted laparoscopic prostatectomy and extended pelvic lymph node dissection as a monotherapy in patients with very high-risk prostate cancer Patients<\/strong> Predictors of Hypotension after Adrenalectomy for Pheochromocytoma<\/strong> Myofiber androgen receptor increases muscle strength mediated by a skeletal muscle splicing variant of Mylk4.<\/strong> Development and validation of a prediction model for failed shockwave lithotripsy of upper urinary tract calculi using computed tomography information: the S(3)HoCKwave score<\/strong> SPOP is essential for DNA-protein cross-link repair in prostate cancer cells: SPOP-dependent removal of topoisomerase 2A from the topoisomerase 2A-DNA cleavage complex<\/strong> Feasibility of Laparoscopic Radical Cystectomy in Elderly Patients: A Comparative Analysis of Clinical Outcomes in a Single Institution<\/strong> A Case Report of Synchronous Prostate Cancer and Rectal Gastrointestinal Stromal Tumor and its Management<\/strong> New classification of hydronephrosis on 18F-FDG-PET\/CT predicts post-operative renal function and muscle-invasive disease in patients with upper urinary tract urothelial carcinoma<\/strong> A case of retroperitoneal fibrosis responding to steroid therapy<\/strong>
Watanabe R, Miura N, Kikugawa T, Saika T, Haffner MC, Nelson PS.
Urol Oncol.<\/em> 2026 Apr;44(4):110987.
PMID: 41605126<\/a><\/p>\n\n\n\n
Watanabe R, Fukumoto T, Miura N, Kurata M, Kitazawa R, Kikugawa T, Saika T.
Sci Rep.<\/em> 2025 Nov 27;15(1):42470.
PMID: 41309810<\/a><\/p>\n\n\n\n
Watanabe R, Kagimoto K, Chosei M, Sakaue T, Kurata M, Miura N, Kitazawa R, Kikugawa T, Higashiyama S, Saika T.
Cells.<\/em> 2025 Jan 22;14(3):165.
PMID: 39936957<\/a><\/p>\n\n\n\n
Sawada Y, Kikugawa T, Onishi T, Arai O, Iio H, Miura N, Yoshida S, Ikedo A, Yanagihara Y, Saeki N, Sakakibara I, Gy\u0151rffy B, Kishida T, Okubo Y, Nakamura Y, Sato S, Miyagi Y, Saika T, Imai Y.
Int J Cancer. 2025 Dec 1;157(11):2399-2412.<\/em>PMID: 40542593<\/a><\/p>\n\n\n\n
Watanabe R, Miura N, Kurata M, Kitazawa R, Kikugawa T, Saika T.
Int J Mol Sci.<\/em> 2023 May 18;24(10):8955.
PMID: 37240308<\/a><\/p>\n\n\n\n
Watanabe R, Maekawa M, Kiyoi T, Kurata M, Miura N, Kikugawa T, Higashiyama S, Saika T.
Prostate.<\/em> 2021 Dec;81(16):1390-1401.
PMID: 34516672<\/a><\/p>\n\n\n\n
Watanabe R, Maekawa M, Hieda M, Taguchi T, Miura N, Kikugawa T, Saika T, Higashiyama S.
Mol Biol Cell.<\/em> 2020 Mar 15;31(6):478-490.
PMID: 31967940<\/a><\/p>\n\n\n\n\u5f53\u7814\u7a76\u7d44\u7e54\u306e\u7814\u7a76\u6210\u679c\u3092\u3001\u65b0\u3057\u3044\u3082\u306e\u304b\u3089\u5e74\u4ee3\u9806\u306b\u63b2\u8f09\u3057\u3066\u3044\u307e\u3059\u3002<\/h2>\n\n\n\n
2026\u5e74<\/h2>\n\n\n\n
Watanabe R.
Int J Urol. 2026 Aug;33(8):e70604.<\/em>PMID: 42583697<\/a><\/p>\n\n\n\n
Sugihara N, Sawada T, Arai H, Nishida K, Ohnishi T, Watanabe R, Nishimura K, Fukumoto T, Miura N, Miyauchi Y, Saika T.
Int J Urol. 2026 Aug;33(8):e70595.<\/em>PMID: 42576438<\/a><\/p>\n\n\n\n
Oono T, Terashita M, Mori S, Oka A, Matsuzaki S, Yano A, Matsumura M, Ninomiya I, Shinomori K, Ogawa T, Onishi T, Shirato A, Watanabe Y, Hashine K, Yamashita N, Watanabe R, Miura N, Saika T.
Int J Urol. 2026 Aug;33(8):e70592.<\/em>PMID: 42576432<\/a><\/p>\n\n\n\n
Watanabe R, Chosei M, Arai H, Miura N, Kikugawa T, Saika T.
Front Oncol. 2026 Jul 24;16:1870253.<\/em>PMID: 42568401<\/a><\/p>\n\n\n\n
Shimizu R, Morizane S, Yamaguchi N, Katayama S, Kawada T, Bekku K, Kobayashi K, Shiraishi K, Miura N, Watanabe R, Tohi Y, Naito H, Yamamoto S, Inoue K, Takamoto A, Daizumoto K, Furukawa J, Ogawa K, Wada K, Takenaka A.
Nutr Cancer. 2026;78(7):539-549.<\/em>PMID: 42394479<\/a><\/p>\n\n\n\n
Watanabe R, Chosei M, Sakaue T, Miura N, Kikugawa T, Saika T.
Int J Mol Sci. 2026 Jun 16;27(12):5405.<\/em>PMID: 42353123<\/a><\/p>\n\n\n\n
Watanabe R, Chu T, Miura N, Kikugawa T, Nelson PS, Saika T.
Am J Clin Exp Urol. 2026 Jun 15;14(3):64-85.<\/em>PMID: 42488354<\/a><\/p>\n\n\n\n
Watanabe R, Shigehisa R, Kawada T, Yamamoto S, Katayama S, Takamoto A, Nishimura K, Miura N, Araki M, Inoue K, Saika T; Chu-shikoku Japan Urological Consortium (CsJUC) Research Collaboration.
Anticancer Res. 2026 Apr;46(4):1929-1942.<\/em>PMID: 41895744<\/a><\/p>\n\n\n\n
Watanabe R, Sakaue T, Miura N, Kikugawa T, Saika T.
Mol Med Rep. 2026 Apr;33(4):122.<\/em>PMID: 41789574<\/a><\/p>\n\n\n\n
Watanabe R, Miura N, Kikugawa T, Saika T, Haffner MC, Nelson PS.
Urol Oncol. 2026 Apr;44(4):110987.<\/em>PMID: 41605126<\/a><\/p>\n\n\n\n
Haga S, Watanabe R, Kurata M, Miura N, Liu S, Kikugawa T, Kitazawa R, Mogi M, Saika T.
Discov Oncol. 2026 Mar 31;17(1):722.<\/em>PMID: 41917522<\/a><\/p>\n\n\n\n
Miura N, Shimbo M, Shishido K, Nobumori S, Sugihara N, Sawada T, Haga S, Arai H, Nishida K, Arai O, Onishi T, Watanabe R, Nishimura K, Fukumoto T, Miyauchi Y, Kikugawa T, Nishino T, Endo F, Hattori K, Saika T.
Int J Urol. 2026 Feb;33(2):e70366.<\/em>PMID: 41623210<\/a><\/p>\n\n\n\n
Sugihara N, Kono R, Sogabe H, Saiki K, Arai H, Arai O, Onishi T, Kakuda T, Hara K, Watanabe R, Miura N, Ozawa A, Iseda T, Saika T.
BMC Urol. 2026 Jan 10;26(1):36.<\/em>PMID: 41514222<\/a><\/p>\n\n\n\n
Katayama S, Iwata T, Nishimura S, Bekku K, Kobayashi K, Fujii N, Nishimura K, Miura N, Tohi Y, Kato T, Yamamoto S, Fukuhara H, Takamoto A, Shimizu R, Morizane S, Sasaki Y, Daizumoto K, Nagami T, Wada K, Araki M; Chu-shikoku Japan Urological Consortium.
Jpn J Clin Oncol. 2026 Jan 9;56(1):89-96.<\/em>PMID: 41124086<\/a><\/p>\n\n\n\n
Watanabe R.
Int J Urol. 2026 Jan;33(1):e70317.<\/em>PMID: 41368771<\/a><\/p>\n\n\n\n2025\u5e74<\/h2>\n\n\n\n
Watanabe R, Miura N, Kikugawa T, Saika T.
Biomedicines. 2025 Dec 25;14(1):52.<\/em>PMID: 41595588<\/a><\/p>\n\n\n\n
Watanabe R, Fukumoto T, Miura N, Kurata M, Kitazawa R, Kikugawa T, Saika T.
Sci Rep. 2025 Nov 27;15(1):42470.<\/em>PMID: 41309810<\/a><\/p>\n\n\n\n
Arai O, Yanagihara Y, Arai H, Watanabe R, Miura N, Kikugawa T, Saika T, Imai Y.
Cancer Med. 2025 Nov;14(22):e71399.<\/em>PMID: 41263259<\/a><\/p>\n\n\n\n
Miura N, Shimbo M, Shishido K, Nobumori S, Sugihara N, Sawada T, Haga S, Arai H, Nishida K, Arai O, Onishi T, Watanabe R, Nishimura K, Fukumoto T, Miyauchi Y, Kikugawa T, Nishino T, Endo F, Hattori K, Saika T.
Cancers (Basel). 2025 Oct 10;17(20):3286.<\/em>PMID: 41154343<\/a><\/p>\n\n\n\n
Watanabe R.
Int J Urol. 2025 Sep;32(9):1283-1284.<\/em>PMID: 40524379<\/a><\/p>\n\n\n\n
Sugihara N, Watanabe R, Miura N, Saika T, Ohashi K.
IJU Case Rep. 2025 Aug 15;8(5):521-524.<\/em>PMID: 40909304<\/a><\/p>\n\n\n\n
Fukumoto T, Sawada T, Nishida K, Onishi T, Watanabe R, Nishimura K, Miura N, Miyauchi Y, Kikugawa T, Saika T.
J Clin Med. 2025 Apr 24;14(9):2954.<\/em>PMID: 40363986<\/a><\/p>\n\n\n\n
Obinata D, Yamada Y, Sumiyoshi T, Tanegashima T, Watanabe R, Kobayashi H, Ito D, Urabe F; Japanese Young Urologist Basic Research Collaboration.
Int J Urol. 2025 Mar;32(3):219-228.<\/em>PMID: 39474871<\/a><\/p>\n\n\n\n
Miura N, Shimbo M, Okawa D, Sakamoto M, Sugihara N, Sawada T, Haga S, Arai H, Nishida K, Arai O, Onishi T, Watanabe R, Nishimura K, Fukumoto T, Miyauchi Y, Kikugawa T, Nishino T, Endo F, Hattori K, Saika T.
Cancers (Basel). 2025 Feb 14;17(4):655.<\/em>PMID: 40002250<\/a><\/p>\n\n\n\n
Watanabe R, Kagimoto K, Chosei M, Sakaue T, Kurata M, Miura N, Kitazawa R, Kikugawa T, Higashiyama S, Saika T.
Cells. 2025 Jan 22;14(3):165.<\/em>PMID: 39936957<\/a><\/p>\n\n\n\n
Shiode R, Watanabe R, Kakuda T, Suzuki D, Nobumori S, Sugihara N, Yamakawa M, Saiki K, Kono R, Noda T, Nishimura K, Fukumoto T, Miura N, Miyauchi Y, Kikugawa T, Saika T.
Asian J Endosc Surg. 2025 Jan-Dec;18(1):e70054.<\/em>PMID: 40210236<\/a><\/p>\n\n\n\n
Sawada Y, Kikugawa T, Onishi T, Arai O, Iio H, Miura N, Yoshida S, Ikedo A, Yanagihara Y, Saeki N, Sakakibara I, Gy\u0151rffy B, Kishida T, Okubo Y, Nakamura Y, Sato S, Miyagi Y, Saika T, Imai Y.
Int J Cancer. 2025 Dec 1;157(11):2399-2412.<\/em>PMID: 40542593<\/a><\/p>\n\n\n\n2024\u5e74<\/h2>\n\n\n\n
Watanabe R, Miura N, Kurata M, Kitazawa R, Kikugawa T, Saika T.
Cureus. 2024 Dec 21;16(12):e76165.<\/em>PMID: 39840193<\/a><\/p>\n\n\n\n
Arai H, Sogabe H, Morikawa S, Arai O, Watanabe R, Ozawa A, Hida AI, Iseda T, Kohashi K, Oda Y.
Int Cancer Conf J. 2024 Apr 30;13(3):301-305.<\/em>PMID: 38962045<\/a><\/p>\n\n\n\n
Watanabe R, Miura N, Kurata M, Kitazawa R, Kikugawa T, Saika T.
Int J Mol Sci. 2024 Apr 28;25(9):4818.<\/em>PMID: 38732035<\/a><\/p>\n\n\n\n2023\u5e74<\/h2>\n\n\n\n
Watanabe R, Miura N, Kurata M, Kitazawa R, Kikugawa T, Saika T.
Int J Mol Sci. 2023 May 18;24(10):8955.<\/em>PMID: 37240308<\/a><\/p>\n\n\n\n2022\u5e74<\/h2>\n\n\n\n
Nishimura K, Konishi T, Ochi T, Watanabe R, Noda T, Fukumoto T, Miura N, Miyauchi Y, Kikugawa T, Takenaka K, Saika T.
J Pers Med. 2022 May 28;12(6):888.<\/em>PMID: 35743673<\/a><\/p>\n\n\n\n
Sakai H, Sawada Y, Tokunaga N, Tanaka K, Nakagawa S, Sakakibara I, Ono Y, Fukada SI, Ohkawa Y, Kikugawa T, Saika T, Imai Y.
iScience. 2022 Feb 14;25(3):103928.<\/em>PMID: 35243267<\/a><\/p>\n\n\n\n2021\u5e74<\/h2>\n\n\n\n
Watanabe R, Maekawa M, Kiyoi T, Kurata M, Miura N, Kikugawa T, Higashiyama S, Saika T.
Prostate. 2021 Dec;81(16):1390-1401.<\/em>PMID: 34516672<\/a><\/p>\n\n\n\n
Miura N, Sugihara N, Funaki K, Kakuda T, Koyama K, Watanabe R, Sawada Y, Noda T, Nishimura K, Fukumoto T, Miyauchi Y, Kikugawa T, Saika T.
Cancer Med. 2021 Nov;10(22):7968-7976.<\/em>PMID: 34562303<\/a><\/p>\n\n\n\n
Koyama K, Miura N, Watanabe R, Sawada Y, Noda T, Nishimura K, Asai S, Fukumoto T, Yanagihara Y, Miyauchi Y, Kikugawa T, Saika T.
Acta Med Okayama. 2021 Jun;75(3):345-349.<\/em>PMID: 34176938<\/a><\/p>\n\n\n\n
Sakakibara I, Yanagihara Y, Himori K, Yamada T, Sakai H, Sawada Y, Takahashi H, Saeki N, Hirakawa H, Yokoyama A, Fukada SI, Sawasaki T, Imai Y.
iScience. 2021 Mar 13;24(4):102303.<\/em>PMID: 33870126<\/a><\/p>\n\n\n\n2020\u5e74<\/h2>\n\n\n\n
Yoshioka T, Ikenoue T, Hashimoto H, Otsuki H, Oeda T, Ishito N, Watanabe R, Saika T, Araki M, Fukuhara S, Yamamoto Y; Okayama-Ehime S.W.L. Study Group.
World J Urol. 2020 Dec;38(12):3267-3273.<\/em>PMID: 32088747<\/a><\/p>\n\n\n\n
Watanabe R, Maekawa M, Hieda M, Taguchi T, Miura N, Kikugawa T, Saika T, Higashiyama S.
Mol Biol Cell. 2020 Mar 15;31(6):478-490.<\/em>PMID: 31967940<\/a><\/p>\n\n\n\n2019\u5e74<\/h2>\n\n\n\n
Yanagihara Y, Nishida K, Watanabe R, Koyama K, Sawada Y, Noda T, Asai S, Fukumoto T, Miura N, Miyauchi Y, Kikugawa T, Saika T.
Acta Med Okayama. 2019 Oct;73(5):417-418.<\/em>PMID: 31649367<\/a><\/p>\n\n\n\n
Watanabe R, Ozawa A, Iseda T, Hatano H.
Urol J. 2019 Jun 17;16(3):322-325.<\/em>PMID: 30206927<\/a><\/p>\n\n\n\n2018\u5e74<\/h2>\n\n\n\n
Asai S, Fukumoto T, Watanabe R, Koyama K, Sawada Y, Noda T, Miura N, Yanagihara Y, Miyauchi Y, Miyagawa M, Kikugawa T, Saika T.
Jpn J Clin Oncol. 2018 Nov 1;48(11):1022-1027.<\/em>PMID: 30252103<\/a><\/p>\n\n\n\n2017\u5e74<\/h2>\n\n\n\n
Watanabe R, Ozawa A, Iseda T.
Int Braz J Urol. 2017 Nov-Dec;43(6):1185-1189.<\/em>PMID: 28379669<\/a><\/p>\n\n\n\n2016\u5e74<\/h2>\n\n\n\n